Marshall Wace, LLP Neuro Sense Therapeutics Ltd. Transaction History

Marshall Wace, LLP

  • $81.7 Billion
  • Q2 2025

A detailed history of Marshall Wace, LLP transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 11,828 shares of NRSN stock, worth $14,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,828
Holding current value
$14,903
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$0.91 - $2.49 $10,763 - $29,451
11,828 New
11,828 $22,000

Others Institutions Holding NRSN

# of Institutions
14
Shares Held
385K
Call Options Held
0
Put Options Held
0
View Full List

About NeuroSense Therapeutics Ltd.

NRSN Quotes by TradingView
  • Ticker NRSN
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,674,000
  • Market Cap $14.7M
More about NRSN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email